689254-23-7 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Difluoro-4-methoxybenzyl bromide serves as a crucial intermediate in the synthesis of pharmaceutical products. Its fluorine and methoxy groups can be strategically incorporated into drug molecules to improve their pharmacokinetic and pharmacodynamic properties, such as enhancing solubility, bioavailability, and target specificity.
Used in Agrochemical Industry:
In the agrochemical sector, 2,3-difluoro-4-methoxybenzyl bromide is utilized for the production of various agrochemicals. 2,3-DIFLUORO-4-METHOXYBENZYL BROMIDE's functional groups can be integrated into molecules to develop new pesticides or herbicides with improved efficacy and selectivity, contributing to more effective crop protection.
Used in the Synthesis of Bioactive Compounds:
2,3-Difluoro-4-methoxybenzyl bromide is also employed in the synthesis of compounds with potential biological activities. Its unique structure allows for the creation of molecules with anti-tumor and anti-microbial properties, which can be further explored and developed for therapeutic applications.
However, due to its corrosive and toxic nature, 2,3-difluoro-4-methoxybenzyl bromide requires careful handling and storage to ensure safety in its applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 689254-23-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,9,2,5 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 689254-23:
(8*6)+(7*8)+(6*9)+(5*2)+(4*5)+(3*4)+(2*2)+(1*3)=207
207 % 10 = 7
So 689254-23-7 is a valid CAS Registry Number.
689254-23-7Relevant academic research and scientific papers
Xofluza sulfur-containing heterocyclic compound, intermediate and preparation method thereof
-
Paragraph 0114-0116, (2020/03/17)
The invention discloses an Xofluza sulfur-containing heterocyclic compound, an intermediate and a preparation method thereof, and provides a preparation method of a compound represented by a formula 5. The preparation method is mild in reaction condition,
PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE
-
Page/Page column 50-51, (2008/12/07)
The invention relates toa pharmaceutical composition comprising a pyrazole-O-glucoside derivative selected from the group of compounds (1) to (29) according to claim 1 in combination with at least one second therapeutic agent which is suitable in the trea
METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES
-
Page/Page column 36; 37, (2010/11/25)
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for
Sulfonamides
-
Page/Page column 57, (2010/02/15)
The invention relates to compounds of the general formula in which R1, R2, R3, R4, R2′, R3′, R4′, R5, and X is —CHR— are as defined in the specification. The invention also provides pharmac
